Collaborative Program Grant for Multidisciplinary Teams (RM1)
natural products as starting points for drug discovery and development. Project Summary We have assembled an entirely Florida-centric collaborative research team
Showing 41 - 50 of 234 results
natural products as starting points for drug discovery and development. Project Summary We have assembled an entirely Florida-centric collaborative research team
Professor Hendrik Luesch, a global leader in marine natural product drug discovery and development, shares insights into his research
pandemic. Hendrik Luesch, Ph.D., a professor and chair of medicinal chemistry and the Debbie and Sylvia DeSantis Chair in Natural Products Drug Discovery and Development
FOR NATURAL PRODUCTS, DRUG DISCOVERY & DEVELOPMENT LOGO DOWNLOAD
tetrapeptide natural product CJ-15,208 was reported to be a KOR antagonist in vitro (Saito et al., J. Antibiot. 2002, 55, 847-854). Because of its macrocyclic structure we expected
of medicinal agents, natural products chemistry, prodrugs, topical drug delivery, peptide chemistry, molecular modeling, drug metabolism and molecular toxicology. Pharmaceutical
science backgrounds a rewarding and challenging program of study. Areas of research interests include drug discovery, organic synthesis of medicinal agents, natural products
agents, natural products chemistry, prodrugs, topical drug delivery, peptide chemistry, molecular modeling, drug metabolism and molecular toxicology. Pharmaceutical Outcomes and Policy
To fully harness the biosynthetic potential of the organisms that produce these natural products, the CNPD3 will obtain the genomic and metagenomic DNA. The focus here
Professor Hendrik Luesch, a global leader in marine natural product drug discovery and development, shares insights into his research and his joint appointment at Duke-NUS Medical School and the University of Florida.